PAncreatic Disease Cohort of TOuLouse

Recruiting now

Conditions studied: Pancreatic Diseases

In brief

This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.

Key facts

Study ID

NCT05824403

Run by

University Hospital, Toulouse

People needed

300

Starts

2023-11-28

Expected to finish

2027-12-01

Last updated by the study team

2023-12-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with inflammatory or cystic exocrine pancreatic pathology
• Patient able to read and understand the information leaflet
• Patients who have agreed to participate in the study and have signed the free and informed consent
• Patients affiliated to a social security system (including AME)

You may not qualify if…

• Patient with pancreatic cancer pathology
• Patients with active cancer, whatever the origin
• Pregnant or breastfeeding patients
• Patients under legal protection, guardianship or trusteeship

Where it is running

• Rangueil hospital — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.